# EDGAR Filing Document

**Accession Number:** 0001625579
**File Stem:** 0001225208-23-001581
**Filing Date:** 2023-2
**Character Count:** 8205
**Document Hash:** 9578f2a14d36c17bf3d097ea901ae6f5
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001225208-23-001581.hdr.sgml**: 20230208

**ACCESSION NUMBER**: 0001225208-23-001581

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20230206

**FILED AS OF DATE**: 20230208

**DATE AS OF CHANGE**: 20230208

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Granger Elder
- **CENTRAL INDEX KEY:** 0001625579

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-38769
- **FILM NUMBER:** 23600679

**BUSINESS ADDRESS:**
- **BUSINESS PHONE:** (303)524-9476

**MAIL ADDRESS:**
- **STREET 1:** 5176 S. LEWISTON WAY
- **CITY:** CENTENNIAL
- **STATE:** CO
- **ZIP:** 80015
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Cigna Corp
- **CENTRAL INDEX KEY:** 0001739940
- **STANDARD INDUSTRIAL CLASSIFICATION:** HOSPITAL & MEDICAL SERVICE PLANS [6324]
- **IRS NUMBER:** 824991898
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 900 COTTAGE GROVE ROAD
- **CITY:** BLOOMFIELD
- **STATE:** CT
- **ZIP:** 06002
- **BUSINESS PHONE:** 8602266000

**MAIL ADDRESS:**
- **STREET 1:** 900 COTTAGE GROVE ROAD
- **CITY:** BLOOMFIELD
- **STATE:** CT
- **ZIP:** 06002

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Halfmoon Parent, Inc.
- **DATE OF NAME CHANGE:** 20180508

## Ex-24

```

POWER OF ATTORNEY

	KNOW ALL PERSONS BY THESE PRESENTS, that the undersigned, a Director of Cigna
Corporation, a Delaware corporation ("Cigna"), hereby makes, designates,
constitutes and appoints NICOLE S. JONES, KARI KNIGHT STEVENS, NEIL B. TANNER,
GENEVA CAMPBELL BROWN and KEVIN CIAGLO, each acting individually, as the
undersigned's true and lawful attorneys-in-fact and agents, with full power and
authority to act in the undersigned's capacity as a Director of Cigna for and in
  the name, place and stead of the undersigned to execute and deliver:

(A)		in connection with the filing with the Securities and Exchange Commission
pursuant to the Securities Act of 1933 or the Securities Exchange Act of 1934,
both as amended, of:

(i) Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities
Exchange Act of 1934, Forms 144 in accordance with Rule 144 promulgated under
the Securities Act of 1933 and any and all other documents related thereto
(including, but not limited to, Seller's Representation Letters) and to take
further action as they, or any of them, deem appropriate in connection with the
foregoing.

	Such attorneys-in-fact and agents, or any of them, are also hereby granted full
    power and authority, on behalf of and in the name, place and stead of the
undersigned, to execute and deliver any and all such other documents, and to
take further action as they, or any of them, deem appropriate in connection with
  the foregoing.  The powers and authorities granted herein to such
attorneys-in-fact and agents, and each of them, also include the full right,
power and authority to effect necessary or appropriate substitutions or
revocations.

	The undersigned hereby ratifies, confirms, and adopts, as his or her own act
and deed, all action lawfully taken by such attorneys-in-fact and agents, or any
  of them, or by their respective substitutes, pursuant to the powers and
authorities herein granted.  This Power of Attorney with respect to Forms 3, 4,
5 and 144 shall remain in full force and effect until:, the undersigned no
longer has responsibilities relating to Section 16 of the Securities Exchange
Act of 1934 or Rule 144 promulgated under the Securities Act of 1933 with
respect to the undersigned's beneficial ownership of securities of Cigna, unless
  earlier revoked by the undersigned in a signed writing to each such attorney
in fact.

	IN WITNESS WHEREOF, the undersigned has executed this document as of
the 17th day of January, 2023.

__/s/ Elder Granger_____________
Signature

__Elder Granger________________
Print Name

```

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Granger Elder<br><sub>(Last) (First) (Middle)</sub><br>900 COTTAGE GROVE ROAD<br><sub>(Street)</sub><br>BLOOMFIELD, CT 06002<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2023-02-06 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [ ] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Cigna Corp [ CI ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock, $.01 Par Value | 2023-02-06 |  | G |  | 200 | D | $0 | 4489 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |

---

**Remarks:**
Exhibit List: EX-24 Power of Attorney   poagranger.txt

**Signature:** Kevin Ciaglo, attorney-in-fact  
**Date:** 2023-02-08

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**